FDA Approved: VIVJOA — Supplemental Application (Mycovia Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VIVJOA (oteseconazole) submitted by Mycovia Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• VIVJOA (oteseconazole)

Snippet

SUPPL AP for VIVJOA (OTESECONAZOLE)